Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations

10.1080/15384047.2016.1195049<br/>Matjaz Zwitter

from Cancer via ola Kala on Inoreader http://ift.tt/29asSzw
via IFTTT